Use of PCR Cycle Threshold and Clinical Interventions to Aid in the Management of Pediatric Clostridioides difficile Patients

被引:0
|
作者
Suleiman, Mohammed [1 ]
Tang, Patrick [1 ,2 ]
Imam, Omar [3 ]
Morales, Princess [1 ]
Altrmanini, Diyna [1 ]
Barr, Kelli L. [4 ]
Roberts, Jill C. [4 ]
Perez-Lopez, Andres [1 ,2 ]
机构
[1] Sidra Med, Dept Pathol, POB 26999, Doha, Qatar
[2] Weill Cornell Med Qatar, Dept Pathol & Lab Med, POB 24144, Doha, Qatar
[3] Sidra Med, Dept Infect Prevent & Control, POB 26999, Doha, Qatar
[4] Univ S Florida, Ctr Global Hlth & Infect Dis Res, Tampa, FL 33612 USA
关键词
Clostridioides difficile; pediatric; children; cycle threshold; intervention; INFECTION; IMPACT; EPIDEMIOLOGY; DIAGNOSIS; PREDICTS; CHILDREN;
D O I
10.3390/microorganisms12061181
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Better diagnostic tools are needed to improve the diagnosis of Clostridioides difficile infections (CDI) and reduce the overtreatment of colonized children. In this study, we evaluated two polymerase chain reaction (PCR) assays (Cepheid GeneXpert C. difficile and the Gastroenteritis PCR Panel by QIAstat-Dx) as a standalone method in combination with the PCR cycle threshold (Ct) value in positive samples to predict the presence of free toxins. We also evaluated the clinical impact of reporting toxin production results and provided comments alongside the PCR results in our pediatric population. PCR-positive stool samples from pediatric patients (aged 2 to 18 years old) were included in our study and tested for the presence of toxins A and B using the C. difficile Quik Chek Complete kit. For the clinical intervention, the CDI treatment rates 6 months pre- and post-intervention were compared. The use of PCR Ct value showed excellent sensitivity (100%) at a Ct value cutoff of 26.1 and 27.2 using the Cepheid GeneXpert C. difficile and the Gastroenteritis PCR Panel by QIAstat-Dx, respectively, while the toxin test showed inferior sensitivity of 64% in the PCR-positive samples. In addition, CDI treatment rates were decreased by 23% post-intervention. The results of our study suggest that nucleic acid amplification test (NAAT) assays supplemented by the use of PCR Ct value for positive samples can be used as standalone tests to differentiate CDI from colonization. Furthermore, the reporting of toxin production along with the PCR results can help reduce the unnecessary treatment of colonized children.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Clinical Impact of Clostridium difficile PCR Cycle Threshold-Predicted Toxin Reporting in Pediatric Patients
    Schwenk, Hayden T.
    Bio, Laura L.
    Kruger, Jenna F.
    Banaei, Niaz
    JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2020, 9 (01) : 44 - 50
  • [2] The Utility of Clostridioides difficile PCR Cycle Threshold in Patients With Post-Infection Irritable Bowel Syndrome
    Moktan, Varun
    Lacy, Brian E.
    Koop, Andree
    Werlang, Monia
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S232 - S232
  • [3] Clostridioides (Clostridium) difficile PCR Amplification Cycle Threshold: More Than Just a Number?
    Tung, William
    Hunold, Thomas
    Poulter, Melinda D.
    Warren, Cirle
    Wu, Martin
    Hays, R. Ann
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S129 - S129
  • [4] Novel Biomarkers, Including tcdB PCR Cycle Threshold, for Predicting Recurrent Clostridioides difficile Infection
    Madden, Gregory R.
    Rigo, Isaura
    Boone, Rachel
    Abhyankar, Mayuresh M.
    Young, Mary K.
    Basener, William
    Petri Jr, William A. A.
    INFECTION AND IMMUNITY, 2023, 91 (04)
  • [5] Clostridioides difficile PCR Tcdb Cycle Threshold predicts toxin EIA positivity but not severity of infection
    Mah, Regan
    Locher, Kerstin
    Steiner, Theodore S.
    Stefanovic, Aleksandra
    ANAEROBE, 2023, 82
  • [6] Real-time polymerase chain reaction (PCR) cycle threshold and Clostridioides difficile infection outcomes
    Choi, Byungwoo
    Wong, Ken Koon
    Dunn, Aaron N.
    Butler, Robert
    Fraser, Thomas G.
    Procop, Gary W.
    Richter, Sandra S.
    Isada, Carlos M.
    Deshpande, Abhishek
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2021, 42 (10): : 1228 - 1234
  • [7] Fidaxomicin Use in the Pediatric Population with Clostridioides difficile
    Oliver, Meredith B.
    Vaughn, Byron P.
    CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2022, 14 : 91 - 98
  • [8] PCR CYCLE TIME AND CLOSTRIDIOIDES DIFFICILE INFECTION IN HOSPITALIZED PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Moktan, Varun
    Jonica, Emily R.
    Li, Zhuo
    Hata, Jane
    Farraye, Francis A.
    GASTROENTEROLOGY, 2020, 158 (06) : S707 - S707
  • [9] Evaluation of Cycle Threshold, Toxin Concentration, and Clinical Characteristics of Clostridioides difficile Infection in Patients with Discordant Diagnostic Test Results
    Shah, Megan D.
    Balada-Llasat, Joan-Miquel
    Coe, Kelci
    Reed, Erica
    Sandlund, Johanna
    Pancholi, Preeti
    JOURNAL OF CLINICAL MICROBIOLOGY, 2020, 58 (05)
  • [10] Role of Cycle Threshold in Clostridioides difficile Polymerase Chain Reaction Testing as a Predictor of Clinical Outcomes in Patients With Inflammatory Bowel Disease
    Jonica, Emily R.
    Sulis, Carol A.
    Soni, Kanupriya
    Hughes, Michelle
    Jones, Eric
    Weinberg, Janice
    Miller, Nancy S.
    Farraye, Francis A.
    CROHNS & COLITIS 360, 2019, 1 (03)